Objective: Evidence suggests that symptom-triggered benzodiazepine treatment for patients with alcohol withdrawal reduces complication rates and emergency department lengths of stay. Our objective was to describe the management of alcohol withdrawal in 2 urban emergency departments. Methods: A structured chart audit was performed for patients with alcohol-related problems who presented to 2 Toronto hospitals over a 2-year period. Results: A total of 209 emergency department charts were audited. Patient characteristics were similar in both hospitals. None of the patients had been assessed using the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale. Patients at one hospital received substantially higher mean diazepam doses (64 mg v. 26 mg; p < 0.001) than did the patients at the other hospital, and the patients at the first hospital had fewer seizures during their emergency department stay (1% v. 9%; p = 0.012). Patients spent an average of 9 hours and 40 minutes in the emergency department. Conclusion: There is significant variability in the documentation and treatment of alcohol withdrawal. Lower benzodiazepine doses are associated with higher rate of withdrawal seizures and prolonged emergency department length of stay. A standardized approach using symptomtriggered management is likely to improve outcomes for patients presenting with alcohol withdrawal.
Introduction
Alcohol withdrawal is a common and serious problem in the emergency department (ED), accounting for 10%-30% of all ED visits in some studies. [1] [2] [3] [4] [5] [6] Patients with alcohol-related diagnoses are more likely to be frequent users of the ED and to require frequent ambulance transfers. [7] [8] [9] Controlled trials have demonstrated that benzodiazepines reduce the intensity and duration of withdrawal and prevent complications such as seizures and delirium. [10] [11] [12] "Symptom-triggered" treatment, where therapy is based on an objective withdrawal severity scale, 13 provides more rapid and effective relief of withdrawal complications than subjective treatment based on clinicians' judgement alone. [14] [15] [16] [17] [18] [19] The most commonly used withdrawal severity scale is the Clinical Institute Withdrawal Assessment for Alcohol (CIWA-Ar) scale, a validated, reliable 10-item scale measuring tremor, sweating, anxiety and other signs of withdrawal; it can be performed in a few minutes. 13 One example of symptom-triggered treatment is the diazepam-loading protocol, in which 20 mg of oral diazepam is administered every hour if the patient's CIWA-Ar score is 10 or higher. 12 The purpose of this study was to describe the management of alcohol withdrawal in 2 urban EDs, focusing on documentation of withdrawal severity, use of symptomtriggered benzodiazepine treatment, medications provided, ED length of stay and occurrence of seizures.
Methods

Setting
This retrospective chart audit was conducted at 2 urban hospitals in Toronto, Canada. Inner City Hospital (A) is a 350-bed community hospital with a high prevalence of alcohol-and drug-related problems. Downtown Teaching Hospital (B) is a 420-bed hospital serving a community of mixed socio-economic status. Ethics approval was obtained at the 2 sites.
Audit process
The investigators developed a standard audit form and reviewed it in detail with the medical student who conducted the audits (N.L.). Information was collected on demographics, presenting complaint, ED length of stay (LOS), indicators of withdrawal severity (tremor, seizures), blood alcohol level (BAL), benzodiazepine dose administered, laboratory tests and consults ordered, discharge medications, and disposition. Prior to data collection, the student and the principal investigator (M.K.) audited 10 charts, clarified data definitions and reviewed discrepancies to maximize reliability. A random sample of charts with the ICD-9-CM code for alcoholism or alcohol-related problem was also audited. Charts were considered eligible for the study if they met at least one of the following criteria: admitting or discharge diagnosis of alcohol withdrawal; physicians' or nurses' notes describing alcohol withdrawal; mention of tremor or seizures; or a physician's ED order or discharge prescription for benzodiazepines.
Patient eligibility
Outcomes
Key outcome variables included total diazepam dose per patient, the occurrence of seizures in ED, and total ED length of stay, by hospital. On a établi un lien avec des doses plus faibles de benzodiazépines, un taux plus élevé de convulsions liées au sevrage et un séjour plus long à l'urgence. Une démarche normalisée fondée sur la prise en charge déclenchée par les symptômes devrait améliorer l'évolution de l'état de santé des patients qui se présentent en état de sevrage de l'alcool.
Data analysis
Descriptive statistics for continuous variables were summarized using means and standard deviations. Categorical variables were summarized as frequencies. The statistical significance of observed differences in continuous outcome variables were determined using t tests, and observed differences in categorical variables were analyzed using the chi-squared or Fisher's exact test for proportions, as appropriate. Unless otherwise specified, all significance tests are 2-sided, and p values <0.05 are considered significant.
Results
A total of 129 charts from Hospital A and 80 charts from Hospital B were audited. Neither hospital used the CIWAAr or any other withdrawal severity scale for any of the 209 patient visits. Table 1 shows that patient characteristics were similar at both hospitals. Most patients were male, and mean age was 45 years. Twenty-one percent of all patients had no family physician. Eighteen percent of the Hospital B patients had no fixed address or lived in a shelter. Most patients walked into the ED (52%), and the Withdrawal Management Service (WMS), a non-medical detoxification unit, was the most common (29%) source of referral for the Hospital A patients. In contrast, 39% of Hospital B patients came by ambulance, and only 1 was sent by WMS. The most common presenting complaints for patients of both hospitals were alcohol withdrawal (26%), intoxication (23%), actual or expected seizures (18%), medical clearance for WMS (18%), tremor (15%), and hallucinations, suicidal ideation or anxiety (12%).
Patient characteristics
Patients were also similar in indicators of withdrawal severity, documented prevalence of tremors, history of prior seizures, and BAL on admission (Table 1) . Tremor was noted in 161 patients (77%) and not documented in 19%. Prior seizure history was noted in 73 patients (35%) and not documented in 52%. There were no significant differences in documentation rates between the 2 hospitals.
Key outcomes (Table 2)
Most patients were treated with diazepam, including 88% at Hospital A and 78% at Hospital B. For patients receiving more than 1 diazepam dose, the median total dose was 60 mg and the time between the first and last dose was 6 hours for both hospitals. Thirty of 48 patients with no documented tremor received diazepam, and 20 patients (9%) received their first dose of diazepam despite a BAL of greater than 35 mmol/L. Table 2 shows that Hospital A provided higher diazepam doses (63.9 mg v. 25.9 mg; p < 0.001) and that this was associated with a lower rate of seizures in the ED: only 1 (0.8%) of 129 Hospital A patients had seizures, compared to 7 (8.8%) of 80 Hospital B patients (p = 0.02). All but 2 patients who had a convulsion had a history of prior seizures.
Patients spent an average of 9 hours and 40 minutes in the ED, and the average number of nursing entries per patient was 9.3, suggesting these patients require substantial nursing and treatment time. Of note, Hospital A patients had a shorter ED length of stay (8 h Based on chart documentation, 81 patients (38.8%) were referred to WMS, 30 (14%) were referred to social work or psychiatry, 30 (14%) were advised to follow up with their family doctor and 3 (1.4%) were referred to addiction medicine service or treatment program. Only 5 patients (2%) had documented advice by the ED physician to reduce their alcohol consumption or attend an alcohol treatment program.
Discussion
This study demonstrates substantial variability in the management and outcomes of patients who present to the ED with alcohol withdrawal. Neither of these 2 busy urban EDs used an objective withdrawal severity scale such as the CIWA-Ar; key predictors like tremor and prior seizures were inconsistently documented; benzodiazepine doses were widely variable across sites; and many patients received diazepam despite high BALs or in the absence of documented tremor. The high seizure rate and relatively lower benzodiazepine dosing patterns seen at Hospital B suggests that patients might have been systematically undertreated at this site.
Since no objective measure of withdrawal severity was used, it is possible that patients at the 2 hospitals were different at baseline; however, we found no differences in terms of the available indicators of withdrawal severity in the documented prevalence of tremor, or with respect to prior seizure history. Groups also had similar risk factors for withdrawal severity, including age and admission BAL. 21 Blood alcohol level correlates well with alcohol consumption in the past few hours, and the amount of alcohol consumption in the days immediately prior to admission is a risk factor for withdrawal severity. 22 Not surprisingly, a high admission BAL is associated with a lower risk of withdrawal seizures in the ED, 23 presumably because intoxicated patients are discharged from the ED before they go into severe withdrawal.
In this study, patients suffering from alcohol withdrawal spent an average of almost 10 hours in the ED, much longer than the average LOS for other non-admitted patients, which was 3 hours for Hospital A and 4.5 hours for Hospital B at the time of the study. Assuming patients at these hospitals received the appropriate total diazepam doses, their ED lengths of stay (time between first and last diazepam administration) could have been reduced from 6 hours to 1 hour (Hospital B), and from 6 hours to 2.75 hours (Hospital A) if diazepam was given 20 mg every hour as recommended in a previously described diazepam loading protocol. 12 Prior evidence suggests that brief physician advice is effective in reducing alcohol consumption among family medicine patients, medical inpatients and ED patients. [24] [25] [26] [27] Physicians should express concern, suggest treatment options such as Acoholics Anonymous or naltrexone, and advise family physician follow-up. Such advice can be pro- vided in a few minutes or less, and from 10%-40% of patients referred from the ED to alcohol treatment programs will follow up as advised. [28] [29] [30] Despite this, physicians in this study rarely counselled patients to reduce their alcohol consumption or attend an alcohol treatment program.
Limitations
This study has the usual limitations of a retrospective chart review. The lack of documentation of history, physical findings or advice does not necessarily mean that these were not done. Tremor rates may have been higher than documented, and the low rate of physician counselling and referral might reflect poor documentation; other studies have shown that physicians tend not to document advice about lifestyle issues. 31 Because we did not follow up patients beyond the ED visit, we did not detect seizures or other adverse outcomes that occurred after ED discharge. While we advocate the use of the CIWA-Ar scale 13 and a diazepam loading protocol, 32,33 these have not been evaluated in the ED setting, and may require shortening or refinement to increase their feasibility for routine ED use.
Conclusion
There is significant variability in the ED documentation and treatment of alcohol withdrawal. Lower benzodiazepine dosing is associated with a higher rate of withdrawal seizures and prolonged ED lengths of stay. A standardized approach using symptom-triggered management is likely to improve outcomes for patients presenting to the ED with alcohol withdrawal.
